CMS Interim Final Rule Falls Short for Home Infusion

Read the statement

April 4, 2020

NHIA Issues COVID-19 Related Recommendations to Commercial Insurers Read recommendations.

Read more

March 30, 2020

Enrollment is Open for the new 2020 Benchmarking Pilot: Status at Discharge and 30-Day Hospital Readmission

Read more

March 18, 2020

NHIA, key stakeholders urge Congress to prioritize home-based care in coronavirus legislation

Read the Release
Read House Letter
Read Senate Letter
Read HHS Letter

March 18, 2020

NHIA cancels 2020 Annual Conference following public health concerns

Read the release

March 12, 2020

Congress introduces legislation for Medicare Part B home infusion fix

Read the release

March 12, 2020

NHIA welcomes Brightree to Future of Infusion Advisory Council

Read the release

Feb 20, 2020

NHIA and 250+ stakeholders urge CMS to overhaul home infusion rules

Read the press release

Feb 14, 2020

NHIA partners with NASP to Offer Certified Specialty Pharmacist Exam Preparatory Course at 2020 Annual Conference Read the release.

Read the press release

Feb 10, 2020

NHIA Submits Comments on CMS solicitation on Scope of Practice.

Read the comments

Jan 21, 2020

NHIA Submits Comments on Proposed Rulemaking for Stark Law and Anti-Kickback Statue

Read the comments

Jan 1, 2020

NHIF announces Q2 2019 home infusion industry patient satisfaction benchmarks

Read the open access report

Dec 30, 2019

NHIA comments on the use of pharmacy technicians in sterile compounding

Read the statement

Dec 18, 2019

NHIA Submits Comments in Response to “Cures 2.0” RFI

Read the comments

Dec 16, 2019

NHIA Submits Comments to CMS on Home Health Final Rule

Read the comments

Download template to submit your comments

Dec 11, 2019

NHIA applauds Senator Isakson for leadership on home infusion

Read the statement

Dec 4, 2019

The National Home Infusion Foundation (NHIF) has announced a public comment period for the next phase of its Benchmarking Program that includes two new metrics to launch in 2020.

NHIA members are encouraged to review the draft benchmarking participation guides for collecting industry-wide outcome data for 30-day Rehospitalizations, and the Status at Discharge for patients receiving infusions in the home or suite setting. A revised definition for the Discharge Reasons is also proposed to support data collection for the new benchmarking metrics. Deadline to submit comment is December 31. Send comments to nhifdata@nhia.org.

See all documents

Dec 3, 2019

NHIA announces 2020 Annual Conference in Denver

Read the release

Nov 15, 2019

Important Facts about Parenteral Selenium (Selenious Acid)

Read the fact sheet

Nov 6, 2019

NHIA expresses disappointment on CMS home health payment rule

Read the Statement

Read the Summary

Stream the Webinar

Nov 1, 2019

White House Releases Proposed Rules on Medicare Value-Based Arrangements

Read the letter

Oct 23, 2019

NHIA calls on American Reagent to Revise Pricing/Stability for Selenious Acid

Read the letter

Oct 4, 2019

NHIA members share insight on home and specialty infusion on Capitol Hill

Read the release

Oct 2, 2019

NHIA submits comments to CMS on ESRD rule urging them not to include E0781 in the “master list”

Read Comments

September 27, 2019

NHIF announces first-ever home infusion industry patient satisfaction benchmarks

Read the open access report

Sept 12, 2019

NHIA and IACP announce co-location of 2020 annual conferences in Denver

Read the release

Sept 10, 2019

NHIA Submits Comments on CMS’ Proposed CY 2020 Home Health Payment Rule

Read Comments

Sept 9, 2019

NHIA Submits Comments on Administration's Patients Over Paperwork Initiative

Read Comments

Aug 20, 2019

NHIA Submits Comments to CMS on Changes to Part B DMEPOS Ig Policy

Read Comments

Aug 20, 2019

NHIA congratulates Option Care and BioScrip on successful merger

Read Media Statement

Aug 8, 2019

NHIA 2020 Annual Conference registration now open

View Website

Aug 5, 2019

NHIA Denounces CMS Proposed Home Infusion Rule

Read the Press Release

Read a Summary of the Proposed Rule

July 16, 2019

NHIA Position Paper: Home Infusion Reimbursement Must Reflect Essential Specialized Pharmacy Professional Services Read the Position Paper

Read the Position Paper

May 21, 2019

NHIA Takes Legal Action Against CMS’ Transitional Payment

Read the complaint
Read the press release
Register for the Webinar

Feb. 15, 2019

HHS Proposed Rule Takes Aim at Drug Rebates from Manufacturers to Health Plans/PBMs, Proposes Safe Harbors to Pass Savings to Consumers and Protect Some Manufacturer-PBM Payments

Read more

Feb. 1, 2019

NHIA Comments on CMS proposal to modernize Part D and Medicare Advantage to lower drug prices

Read more

Jan. 25, 2019

Charron Named COO; Noyes Promoted to Senior Vice President, Reimbursement Policy

Read more

Jan. 9, 2019

NHIA Submits Comments to CMS on Home infusion Transitional Payment

See NHIA's Comments

Dec. 27, 2018

NHIA Accepting Nominations for Gene Graves Award

Submit nomination

Dec. 13, 2018

NHIA Submits Comments to FDA on Draft MOU Addressing Certain Distributions of Compounded Drug Products Between States and FDA

Read NHIA comments

Dec. 10, 2018

Talk Infusion Webinar — Home Infusion Transitional Payment: Staying the Course

Access recording

Dec. 4, 2018

NHIA To Submit Comments on Draft Memorandum of Understanding Addressing Certain Distributions of Compounded Drug Products Between States and the FDA; Comment Deadline is Monday, December 10

Read NHIA comments

Dec. 7, 2018

CMS Issues Details on Transitional Payment to Begin January 1, 2019. Access MLN Matters MM10836 - Temporary Transitional Payment for Home Infusion Therapy Services for CYs 2019 and 2020

Read announcement

Dec. 4, 2018

Sullivan Named NHIA President and CEO

Read announcement

Dec. 4, 2018